Sygnature Discovery has today announced a collaboration with SilcsBio, a scientific software company focused on high-throughput fully atomistic simulations of protein targets and protein-ligand structures. SilcsBio has provided Sygnature with access to its SILCS (Site Identification by Ligand Competitive Saturation) and SSFEP (Single Step Free Energy Perturbation) software. 

BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers. Unlike traditional carbon storage technology that simply collects and stores carbon dioxide, Deep Branch’s carbon recycling solution converts carbon dioxide....

Discovery Park, a thriving high-quality science park playing a key role in the South East of England’s life sciences community,and MedCity, which supports and grows the world-leading life sciences ecosystem of the Greater South East of England, are pleased to announce that they are partnering on the high-profile Angels in Med City programme....

The United Kingdom Accreditation Service (UKAS) has granted accreditation to Malvern-based Validair Monitoring Solutions Limited (VMSL) for Laboratory Calibration services that comply with ISO/IEC 17025:2017. The accreditation is granted with immediate effect following a detailed assessment by UKAS. As a recognised standard,ISO17025 specifies the general requirements for the competence to carry out tests or calibrations....

A major milestone on its strategic mission to lead in sepsis diagnostics, Beckman Coulter has announced that its Early Sepsis Indicator has received 510(k) clearance from the U.S. Food and Drug Administration. Sepsis is a global healthcare crisis that affects more than 30 million people worldwide.1 The Early Sepsis Indicator is a first-of-its-kind, hematology-based cellular...

BioTek’s Synergy™ Neo2 Multi-Mode Microplate Reader offers even more powerful performance and assay flexibility for screening and core laboratories with an optional TRF laser. Along with dual photomultiplier tube (PMT) detection, the 337 nm laser provides the exceptional processing speed and maximum sensitivity necessary for high-quality time-resolved fluorescence....

Research has revealed that a new blood test is able to detect disease relapse up to two years earlier than imaging in patients with early-stage breast cancer. The research, carried out by the University of Leicester and Imperial College London and funded by Cancer Research UK, showed that the blood test was able to detect 89 per cent of all relapses, on average 8.9 months quicker than imaging...